Search Results 211-220 of 10574 for Terminal
German centers only: Treatment with any known non-marketed drug substance or experimental therapy within 5 terminal half lives or 4 weeks prior to ...
Have serious accompanying health problems associated with terminal (e.g., lysosomal storage diseases) or neurodegenerative diseases (e.g., muscular dystrophy).
Students at the end of their occupational or physical therapy terminal degree program that are completing an internship in a traditional model (1:1, one ...
Our long-term goal is to use these study findings to help us design and build a low-cost, high-performance prosthetic hand terminal device that will be ...
HF hospitalization (HFH) within 12 months prior to consent and/or elevated N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) (or Brain Natriuretic ...
Has a prognosis for survival of greater than 3 months and does not have a concurrent diagnosis of a terminal illness or injury, as judged by the clinical team.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!